While each peptide has established research profiles, the blend allows investigation of potential additive or synergistic effectswhether combining different repair mechanisms produces outcomes different from either peptide alone
Clinician oversight Because SLU-PP-332 has no human safety profile, any research planning that involves human exposure should be done under qualified clinician oversight
Xiao B, Xu Z, Viennois E, et al
KLOW peptide is a four-component research blend BPC-157 (50mg), TB-500 (10mg), KPV (10mg), GHK-Cu (10mg) 80mg total in a 3mL lyophilized vial
OUR PRODUCTS ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE
Nasal bioavailability varies depending on formulation, volume per actuation, mucosal contact time, and compound stability in solution